Agenus Data at SITC 2022 Highlight Durable Responses of Botensilimab / Balstilimab Combination in Nine Different Treatment-Resistant Cancers

Written by Biospace | November 14, 2022

New therapeutic addresses need in patients suffering with cold and refractory tumors.

View full post